Liver Tumors in Pediatric Patients.
The most recent advance in the care of children diagnosed with hepatoblastoma and hepatocellular carcinoma is the Pediatric Hepatic International Tumor Trial, which opened to international enrollment in 2018. It is being conducted as a collaborative effort by the pediatric multicenter trial groups in North America, Europe, and the Far East. This international effort was catalyzed by a new unified global risk stratification system for hepatoblastoma, an international histopathologic consensus classification for pediatric liver tumors, and a revised 2017 collaborative update of the PRE-Treatment EXTent of disease radiographic based staging system.
['Meyers|Rebecka|R|', 'Hiyama|Eiso|E|', 'Czauderna|Piotr|P|', 'Tiao|Greg M|GM|']
D006528:Carcinoma, Hepatocellular D002648:Child D018197:Hepatoblastoma D006801:Humans D008113:Liver Neoplasms D015337:Multicenter Studies as Topic
Hepatoblastoma Hepatocellular carcinoma Biliary rhabdomyosarcoma Focal nodular hyperplasia Infantile hemangioma Malignant rhabdoid tumor of the liver Mesenchymal hamartoma PRETEXT Undifferentiated embryonal sarcoma of the liver